Financial Toxicity in Patients Receiving Cancer Immunotherapy Treatments


Researched by Belong.Life and published by ASCORWED of financial toxicity was reported by the majority of cancer pts receiving Immunotherapy drugs for treatment of their solid tumors. 48% of the pts were aware of possible FTs as a result of their diagnosis and therapy. Only 36% received pre-treatment financial advice by their medical team and […]

Evaluating the dyadic management of sexuality-related parameters in women with early breast cancer (EBC): The emergence of “partner reported outcome measurements” (pROMs).


Researched by Belong.Life and published by ASCOexplored sexuality and intimacy-related issues in women with early breast cancer and the resulting partner-reported experience. When a patient’s tumor is located in a sexual organ, the quality of the sexual and intimate lives of both patients and their respective partners can be affected. This study demonstrates the importance […]

Clinical trials participation is directly influenced by the information received by cancer patients (pts) and caregivers: Real-world evidence with the use of a specialized digital health platform.


Researched by Belong.Life and published by ASCOexamined the reasons behind the extremely low level (~3%) of clinical trial participation among cancer patients. Clinical trial participation is crucial for medical advancement and is an important treatment option, at times the only one, for oncology patients. This study highlights the importance for the oncological community to not […]

דילוג לתוכן